[Effects of arginine malate in experimental and clinical hyperammonemia].
D000328:Adult; D000368:Aged; D000641:Ammonia / Q000097:blood*; D000643:Ammonium Chloride / Q000506:poisoning; D000818:Animals; D001120:Arginine / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D008113:Liver Neoplasms / Q000188:drug therapy; D008293:Malates / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects; D011660:Pulmonary Heart Disease / Q000188:drug therapy*; D051381:Rats; D013997:Time Factors; D014680:Veins
D008293:Malates; D000643:Ammonium Chloride; D000641:Ammonia; D001120:Arginine
Wirkung von Arginin-Malat bei experimenteller und klinischer Hyperammoniämie.